Abstract
In this study, we report that the Src substrate Cas (p130 Crk-associated substrate) associates with protein phosphatase 2A (PP2A), a serine/threonine phosphatase. We investigated this interaction in cells expressing a temperature-sensitive mutant form of v-Src. v-Src activation (by shifting cells from the nonpermissive to the permissive temperature) led to an increase in the tyrosine phosphorylation of v-Src and Cas, as well as in the association between v-Src and Cas. v-Src has previously been shown to bind to PP2A and to phosphorylate the catalytic subunit of PP2A, resulting in inhibition of phosphatase activity. We found that the association between v-Src and PP2A decreased as cells were shifted to the permissive temperature. In contrast, the levels of PP2A that co-immunoprecipitated with Cas increased when v-Src was activated. We obtained similar results in pull-down experiments with immobilized Microcystin, a PP2A inhibitor. Serine/threonine phosphorylation of Cas has previously been shown to occur in a cell cycle regulated matter. Treatment of NIH3T3 cells with okadaic acid, a PP2A inhibitor, augments the serine/threonine phosphorylation of Cas that occurs at mitosis. Furthermore, PP2A dephosphorylates serine residues on Cas in vitro. Taken together, our results suggest that PP2A may be involved in the cell cycle-specific dephosphorylation of Cas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brown MT, Cooper JA . 1996 Biochim. Biophys. Acta. 1287: 121–149
Campbell KS, Auger KT, Hemmings BA, Roberts TM, Pallas DC . 1995 J. Virol. 69: 3721–3728
Cayla X, Goris J, Hermann J, Hendrix P, Ozon R, Merlevede W . 1990 Biochemistry 29: 658–667
Chaudhuri SK, Ghosh S, Paweletz N, Schroeter D . 1997 Indian J. Exp. Biol. 35: 1044–1054
Chen J, Martin BL, Brautigan DL . 1992 Science 257: 1261–1264
Chen J, Parsons S, Brautigan DL . 1994 J. Biol. Chem. 269: 7957–7962
Chung H, Brautigan DL . 1999 Cell Signal. 11: 575–580
Evans DR, Hemmings BA . 2000 Mol. Gen. Genet. 264: 425–432
Favre B, Turowski P, Hemmings BA . 1997 J. Biol. Chem. 272: 13856–13863
Garcia P, Shoelson SE, George ST, Hinds DA, Goldberg AR, Miller WT . 1993 J. Biol. Chem. 268: 25146–25151
Garcia-Guzman M, Dolfi F, Russello M, Vuori K . 1999 J. Biol. Chem. 274: 5762–5768
Glenn GM, Eckhart W . 1993 J. Virol. 67: 1945–1952
Glover HR, Brewster CE, Dilworth SM . 1999 Oncogene 18: 4364–4370
Goldberg Y . 1999 Biochem. Pharmacol. 57: 321–328
Goldberg J, Huang HB, Kwon YG, Greengard P, Nairn AC, Kuriyan J . 1995 Nature 376: 745–753
Jove R, Hanafusa H . 1987 Annu. Rev. Cell Biol. 3: 31–56
Jove R, Mayer BJ, Iba H, Laugier D, Poirier F, Calothy G, Hanafusa T, Hanafusa H . 1986 J. Virol. 60: 840–848
Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA . 1998 J. Cell Biol. 140: 961–972
Lin FC, Arndt KT . 1995 EMBO J. 14: 2745–2759
Mayer BJ, Jove R, Krane JF, Poirier F, Calothy G, Hanafusa H . 1986 J. Virol. 60: 858–867
Millward TA, Zolnierowicz S, Hemmings BA . 1999 Trends Biochem. Sci. 24: 186–191
O'Neill GM, Fashena SJ, Golemis EA . 2000 Trends Cell Biol. 10: 111–119
Ogris E, Mudrak I, Mak E, Gibson D, Pallas DC . 1999 J. Virol. 73: 7390–7398
Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL, Roberts TM . 1990 Cell 60: 167–176
Reynolds AB, Roesel DJ, Kanner SB, Parsons JT . 1989 Mol. Cell Biol. 9: 629–638
Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H, Yazaki Y, Hirai H . 1994a EMBO J. 13: 3748–3756
Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Nishida J, Yazaki Y, Hirai H . 1994b J. Biol. Chem. 269: 32740–32746
Schlaepfer DD, Broome MA, Hunter T . 1997 Mol. Cell Biol. 17: 1702–1713
Schlaepfer DD, Hunter T . 1998 Trends Cell Biol. 8: 151–157
Sefton BM, Hunter T, Beemon K . 1980 J. Virol. 33: 220–229
Shenolikar S, Nairn AC . 1991 Adv. Second Messenger Phosphoprotein Res. 23: 1–121
Sheppeck JE, Gauss CM, Chamberlin AR . 1997 Bioorg. Med. Chem. 5: 1739–1750
Turowski P, Fernandez A, Favre B, Lamb NJ, Hemmings BA . 1995 J. Cell Biol. 129: 397–410
Vuori K, Hirai H, Aizawa S, Ruoslahti E . 1996 Mol. Cell Biol. 16: 2606–2613
Yamakita Y, Totsukawa G, Yamashiro S, Fry D, Zhang X, Hanks SK, Matsumura F . 1999 J. Cell Biol. 144: 315–324
Yanagida M, Kinoshita N, Stone EM, Yamano H . 1992 Ciba. Found Symp. 170: 130–146
Yokoyama N . 1995 Mol. Cell Biochem. 148: 123–132
Yokoyama N, Miller WT . 1999 FEBS Lett. 456: 403–408
Zheng B, Woo CF, Kuo JF . 1991 J. Biol. Chem. 266: 10031–10034
Acknowledgements
We thank Dr Steven Anderson for the Ts-72 cells and Dr David Brautigan for the wild-type and inactive (HA)3-tagged H118N-PP2A C subunit plasmids. We thank Barbara Craddock for technical assistance. This work was supported by National Institutes of Health Grants CA28146 and CA58530 (to WT Miller).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yokoyama, N., Miller, W. Protein phosphatase 2A interacts with the Src kinase substrate p130CAS. Oncogene 20, 6057–6065 (2001). https://doi.org/10.1038/sj.onc.1204735
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204735
Keywords
This article is cited by
-
CAS proteins in normal and pathological cell growth control
Cellular and Molecular Life Sciences (2010)
-
p130Cas
AfCS-Nature Molecule Pages (2005)